Due to a combination of a falling share price and several years of EPS growth, CLS's stock has de-rated form close to 50x to high-20 times P/E multiple (mid-20x if R&D expense is normalised).
That, combined with EPS growing in the high-teens means the multi-year under-performance of the stock has finally run its course, I think.
It's Hammer Time.
Ann: Shareholder Information Meetings, page-2
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$287.91 |
Change
-0.700(0.24%) |
Mkt cap ! $139.7B | |||
| Open | High | Low | Value | Volume |
| $287.64 | $288.86 | $287.54 | $85.10M | 292.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 61 | $287.85 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $287.91 | 4 | 2 |
View Market Depth
| Last trade - 10.44am 04/10/2024 (20 minute delay) ? |
| CSL (ASX) Chart |